← Leaderboards
Wendy Marie Campana
University Of California San Diego
$5,242,023
Attributed
$7,753,350
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,753,350 · 6
VA$0 · 3
By mechanism
R01$6,920,034 · 4
R21$434,500 · 1
R43$398,816 · 1
I01$0 · 3
Top collaborators
- Steven L. Gonias4 shared
- Cohava Gelber1 shared
- Gulcin Pekkurnaz1 shared
- Yi Ye1 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Robert R Myers$2,268,691
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainSchwann CellsResponsePreventPainful NeuropathyNeuronsSignal TransductionProteinsInjuryChronic PainChronic Neuropathic PainNerveBehaviorProgramsIn VivoReceptorSignal PathwayResearch Project GrantsPlayInflammatoryAxonRepairedCellsLdl-Receptor Related Protein 1
Grant awards (26)
Targeting LRP1 in Neuroinflammation and Neuropathic Pain$0
I01 · FY2025 · VA · contact PI
Targeting Schwann cell dysfunction and repair signaling in chemotherapy induced painful peripheral neuropathy$2,833,086
R01 · FY2024 · DE
Targeting LRP1 in Neuroinflammation and Neuropathic Pain$0
I01 · FY2024 · VA · contact PI
Regulation of Schwann Cell Mitochondria Homeostasis in Painful Peripheral Neuropathy$434,500
R21 · FY2023 · NS · contact PI
Targeting Schwann cell exosomes for treating neuropathic pain$0
I01 · FY2023 · VA · contact PI
Pre-clinical validation of Phase II peptide LRP-1 agonist to treat and prevent chemotherapy induced peripheral neuropathy.$398,816
R43 · FY2022 · CA
Targeting Schwann cell exosomes for treating neuropathic pain$0
I01 · FY2022 · VA · contact PI
Targeting Schwann cell exosomes for treating neuropathic pain$0
I01 · FY2022 · VA · contact PI
Identifying novel proteins in injured nerves that promote functional regeneration$0
I01 · FY2021 · VA · contact PI
Identifying novel proteins in injured nerves that promote functional regeneration$0
I01 · FY2021 · VA · contact PI
Schwann Cell NMDA Receptor in PNS Injury$339,063
R01 · FY2020 · NS
Identifying novel proteins in injured nerves that promote functional regeneration$0
I01 · FY2020 · VA · contact PI
Targeting Schwann cell exosomes for treating neuropathic pain$0
I01 · FY2020 · VA · contact PI
Schwann Cell NMDA Receptor in PNS Injury$339,063
R01 · FY2019 · NS
Identifying novel proteins in injured nerves that promote functional regeneration$0
I01 · FY2019 · VA · contact PI
Schwann Cell NMDA Receptor in PNS Injury$339,063
R01 · FY2018 · NS
Schwann Cell NMDA Receptor in PNS Injury$339,063
R01 · FY2017 · NS
LRP-1 is a multifunctional regulator during peripheral nerve injury and pain.$331,209
R01 · FY2012 · NS · contact PI
LRP-1 is a multifunctional regulator during peripheral nerve injury and pain.$331,209
R01 · FY2011 · NS · contact PI
LRP-1 is a multifunctional regulator during peripheral nerve injury and pain.$334,590
R01 · FY2010 · NS · contact PI
LRP-1 is a multifunctional regulator during peripheral nerve injury and pain.$337,969
R01 · FY2009 · NS · contact PI
LRP-1 is a multifunctional regulator during peripheral nerve injury and pain.$337,969
R01 · FY2008 · NS · contact PI
Epo-dependent JAK2 Signaling in Painful Neuropathy$259,750
R01 · FY2006 · NS · contact PI
Epo-dependent JAK2 Signaling in Painful Neuropathy$266,000
R01 · FY2005 · NS
Epo-dependent JAK2 Signaling in Painful Neuropathy$266,000
R01 · FY2004 · NS
Epo-dependent JAK2 Signaling in Painful Neuropathy$266,000
R01 · FY2003 · NS